41
Jan Wojcicki, Boguslaw Lilpop, Marek Ziembicki, Stanislaw Bielawski: Device for monitoring the operation of a delivery system and the method of use thereof. Institute of Biocybernetics and Biomedical Engineering P, Novo Nordisk, Steve T Zelson, Elias J Lambiris, March 2, 1993: US05190522 (227 worldwide citation)

A device for monitoring a delivery system comprising a volumetric micropump, a measuring element or sensor located in the infusion line, a matching system and an analyzing system. The devices are preferably for use in insulin administration when treating type-I diabetes and in analytical laboratorie ...


42
Elizabeth A Cummings, Mary E McEvoy, Lars H Berger, Ulrich Kraft, Rainer R Teucher, John C Davis: Analyte testing device. Diabetes Diagnostics, Bernard E Shay, July 10, 2007: US07241265 (220 worldwide citation)

The present invention is a testing device for testing analyte levels in bodily fluids. The testing device comprises memory (202) for storing data, said data being analyte data related to analyte measurements carried out by the meter and lifestyle data; initiation means (102) for initiating immediate ...


43
Volker Tresp, Thomas Briegel: Method and arrangement for the neural modelling of a dynamic system with non-linear stochastic behavior. Siemens Aktiengesellschaft, Schiff Hardin & Waite, August 7, 2001: US06272480 (219 worldwide citation)

In a method and arrangement for the neural modelling of a dynamic system with non-linear stochastic behavior wherein only a few measured values of the influencing variable are available and the remaining values of the time series are modelled, a combination of a non-linear computerized recurrent neu ...


44
Peyser Thomas A, Taub Marc B, Stafford Gary Ashley, Hoss Udo, Morgan Roy E, Lee Daniel H, Mazza John C, Naegeli Andrew H: Medical device insertion. Abbott Diabetes Care, Peyser Thomas A, Taub Marc B, Stafford Gary Ashley, Hoss Udo, Morgan Roy, E, Lee Daniel, H, Mazza John C, Naegeli Andrew H, OH Kuni, October 25, 2007: WO/2007/120363 (219 worldwide citation)

Devices and methods for inserting at least a portion of a medical device in a patient are provided. Embodiments include medical device insertions that employ a plurality of insertion stages. Also provided are systems and kits for use in analyte monitoring.


45
Douglas I Buckley, Joel F Habener, Joanne B Mallory, Svetlana Mojsov: GLP-1 analogs useful for diabetes treatment. Morrison & Foerster, August 13, 1996: US05545618 (218 worldwide citation)

The invention provides effective analogs of the active GLP-1 peptides, 7-34, 7-35, 7-36, and 7-37, which have improved characteristics for treatment of diabetes Type II. These analogs have amino acid substitutions at positions 7-10 and/or are truncated at the C-terminus and/or contain various other ...


46
Boris P Kovatchev, Daniel J Cox: Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data. University of Virginia Patent Foundation, Robert J Decker, April 11, 2006: US07025425 (217 worldwide citation)

A method, system, and computer program product related to the diagnosis of diabetes, and is directed to predicting the long-term risk of hyperglycemia, and the long-term and short-term risks of severe hypoglycemia in diabetics, based on blood glucose readings collected by a self-monitoring blood glu ...


47
Wayne F March: Non-invasive glucose sensor system. Alter and Weiss, March 29, 1977: US04014321 (214 worldwide citation)

A unique glucose sensor to determine the glucose level in patients, for example, for use in treating or diagnosing diabetes. The patient's eye is automatically scanned using a dual source of polarized radiation, each transmitting at a different wavelength at one side of the cornea of the patient. A ...


48
John Eng: Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same. Allegretti & Witcoff, June 13, 1995: US05424286 (214 worldwide citation)

This invention encompasses pharmaceutical compositions containing exendin-3 or exendin-4, fragments thereof, or any combination thereof, and methods for the treatment of diabetes mellitus and the prevention of hyperglycemia.


49
Stafford Gary Ashley: Inserter and methods of use. Abbott Diabetes Care, OH Kuni, February 8, 2007: WO/2007/016399 (214 worldwide citation)

Method and apparatus for providing a housing integrated with a sensor introducer and a sensor in analyte monitoring system to deploy the sensor and retain the introducer within the housing upon sensor deployment, and mounting a transmitter to the housing to receive the sensor data is described. The ...


50
Stafford Gary Ashley: Analyte sensor introducer and methods of use. Abbott Diabetes Care, Stafford Gary Ashley, OH Kuni, March 8, 2007: WO/2007/027788 (212 worldwide citation)

Method and apparatus for providing an introducer for transcutaneous placement of at least a portion of an analyte sensor through the skin of a patient is provided.



Click the thumbnails below to visualize the patent trend.